P643: CUMULATIVE REVIEW OF HEART FAILURE WITH ACALABRUTINIB IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA USING DATA FROM CLINICAL TRIALS AND POST-MARKETING EXPERIENCE

• Paolo Ghia,
• Manan Pareek,
• Shogheeg Apkarian Bourjlian,
• Naghmana Bajwa,
• Anthony J. Corry,
• Suman Jannuru,
• Georg Kreuzbauer,
• Husam Abdel-Qadir

Affiliations

Paolo Ghia

1 Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy

Manan Pareek

2 Center for Translational Cardiology and Pragmatic Randomized Trials, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark

Shogheeg Apkarian Bourjlian

3 AstraZeneca, Gaithersburg, United States

Naghmana Bajwa

3 AstraZeneca, Gaithersburg, United States

Anthony J. Corry

3 AstraZeneca, Gaithersburg, United States

Suman Jannuru

4 AstraZeneca, South San Francisco, United States

Georg Kreuzbauer

5 AstraZeneca, Baar,, Zug, Switzerland

Husam Abdel-Qadir

6 Women’s College Research Institute, Women’s College Hospital, Toronto, Canada